iSpecimen's $200M Solana-Based Treasury: A Catalyst for Biotech and Crypto Convergence
-
最新报道：iSpecimen has allocated $200 million to a Solana-based treasury, integrating blockchain technology into biotech operations to enhance efficiency and data security. Leveraging Solana's high scalability (65,000 TPS) and low-cost microtransactions, the platform enables real-time biospecimen tracking and decentralized data markets. The blockchain integration has reportedly reduced operational costs by 30% while attracting pharmaceutical partners through transparent, auditable supply chains. This strategic move establishes iSpecimen as a crypto-native biotech pioneer, though regulatory uncertainties surrounding Solana-based assets remain a potential challenge.
下一篇
XRP News Today: XRP Classified as Commodity by CFTC Through Event Contracts
- The CFTC has classified XRP as a regulated commodity through Event Contracts, placing it a...
24小时热点
热点专题
413499